Related Experiment Video
Updated: Jul 16, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Chronic obstructive pulmonary disease in women
Louis Laviolette1, Yves Lacasse, Mariève Doucet
1Centre de recherche, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Québec, Canada.
Canadian Respiratory Journal
|March 21, 2007
Summary
Women with chronic obstructive pulmonary disease (COPD) may experience greater lung hyperinflation and benefit more from pulmonary rehabilitation, particularly in managing dyspnea, compared to men. Further research is needed to understand sex-based differences in COPD.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Research
Background:
- Limited understanding of sex-based differences in chronic obstructive pulmonary disease (COPD) impact and response to treatment.
- Investigating gender disparities in COPD is crucial for tailored patient care.
Purpose of the Study:
- To compare lung function, disability, mortality, and response to pulmonary rehabilitation between men and women with COPD.
- To elucidate sex-specific clinical manifestations and treatment outcomes in COPD patients.
Main Methods:
- Retrospective study analyzing data from 68 women and 168 men with COPD.
- Evaluation included pulmonary function tests, exercise tests, 6-minute walk test, and the chronic respiratory questionnaire.
- Survival status was assessed to identify mortality predictors.
Main Results:
- Women exhibited lower tobacco exposure but greater lung hyperinflation (higher functional residual capacity and total lung capacity).
- Pulmonary rehabilitation improved exercise capacity and quality of life in both sexes, with women showing greater dyspnea reduction.
- While overall survival was similar, mortality predictors differed between sexes.
Conclusions:
- Women may be more susceptible to COPD, presenting with distinct clinical features like hyperinflation.
- Pulmonary rehabilitation is beneficial for both sexes, with potentially greater benefits for women regarding dyspnea.
- Sex-specific differences in COPD presentation and outcomes warrant further investigation.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: